A phase I/II trial of amplimexon [imexon] for patients with previously treated multiple myeloma
Phase of Trial: Phase I/II
Latest Information Update: 11 Feb 2008
At a glance
- Drugs Imexon (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Sponsors AmpliMed
- 11 Feb 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.
- 13 Jan 2006 New trial record.